Aura Biosciences, Inc.
AURA
$5.36
-$0.04-0.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 151.09M | 174.38M | 187.42M | 202.87M | 226.15M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.70M | 353.00K | 700.00K | 1.26M | 1.82M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.83M | 8.75M | 7.48M | 8.12M | 3.83M |
| Total Current Assets | 160.62M | 183.48M | 195.60M | 212.25M | 231.79M |
|
|
|||||
| Total Current Assets | 160.62M | 183.48M | 195.60M | 212.25M | 231.79M |
| Net Property, Plant & Equipment | 20.59M | 21.07M | 21.48M | 21.56M | 22.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.29M | 790.00K | 1.21M | 1.22M | 1.28M |
| Total Assets | 182.50M | 205.34M | 218.28M | 235.03M | 255.08M |
|
|
|||||
| Total Accounts Payable | 2.30M | 1.99M | 1.46M | 1.93M | 1.79M |
| Total Accrued Expenses | 8.84M | 8.54M | 5.57M | 4.31M | 6.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.15M | 3.13M | 2.75M | 2.74M | 2.69M |
| Total Finance Division Other Current Liabilities | 618.00K | 1.06M | 768.00K | 682.00K | 935.00K |
| Total Other Current Liabilities | 618.00K | 1.06M | 768.00K | 682.00K | 935.00K |
| Total Current Liabilities | 14.91M | 14.71M | 10.55M | 9.66M | 12.36M |
|
|
|||||
| Total Current Liabilities | 14.91M | 14.71M | 10.55M | 9.66M | 12.36M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.62M | 15.96M | 16.28M | 16.58M | 16.87M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.53M | 30.67M | 26.83M | 26.24M | 29.23M |
|
|
|||||
| Common Stock & APIC | 525.93M | 522.45M | 518.99M | 515.78M | 512.62M |
| Retained Earnings | -374.23M | -348.39M | -327.35M | -307.01M | -287.31M |
| Treasury Stock & Other | 263.00K | 607.00K | -183.00K | 18.00K | 539.00K |
| Total Common Equity | 151.97M | 174.67M | 191.45M | 208.78M | 225.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 151.97M | 174.67M | 191.45M | 208.78M | 225.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 151.97M | 174.67M | 191.45M | 208.78M | 225.85M |
|
|
|||||